20 Years of CIRM: The evolution of a CIRM-funded therapy for macular degeneration

Image Credit: University of Southern California (USC) Eye Institute In celebration of CIRM’s 20th anniversary, we are reflecting on some of the early projects we supported that have since advanced to clinical trials.  One such trial for a form of blindness originated with a 2007 SEED grant to David Hinton, MD, of the University of … Continue reading 20 Years of CIRM: The evolution of a CIRM-funded therapy for macular degeneration

Encouraging news about CIRM-funded clinical trial targeting vision loss

Dry age-related macular degeneration (AMD) is the leading cause of vision loss in the U.S. By 2020 it’s estimated that as many as three million Americans will be affected by the disease. Right now, there is no effective therapy. But that could change. A new CIRM-funded clinical trial is showing promise in helping people battling … Continue reading Encouraging news about CIRM-funded clinical trial targeting vision loss